Skip to main content
TipRanks
Go Ultimate75% OFF

Eli Lilly & Co (LLY) Drug Pipeline

4 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Imlunestrant, Omeprazole, Ly3484356HealthyPhase INot Yet RecruitingA Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsNov 02, 2026
Ly4247147Obesity, OverweightPhase IRecruitingA Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyOct 30, 2026―
Ly3819469, LepodisiranLipoprotein(A)Phase IRecruitingA Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)Oct 29, 2026
Ly3841136, EloralintideObesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2Phase IIINot Yet RecruitingA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 22, 2026
Ly3873862, Cyp450 Drug CocktailAmyotrophic Lateral Sclerosis, Cytochrome P-450 Enzyme SystemPhase INot Yet RecruitingA Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).Oct 14, 2026
Ly4167586Obesity, Overweight, Diabetes Mellitus, Type 2Phase IRecruitingA Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesOct 13, 2026―
Tirzepatide, Eloralintide And TirzepatideObesity, Overweight, Diabetes Mellitus, Type 2Phase IIIRecruitingA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesOct 12, 2026
Tirzepatide, Ly3841136, Eloralintide, Eloralintide And TirzepatideObesityPhase IIINot Yet RecruitingA Study of EloraTZP in Adult Participants With Obesity Without Type 2 DiabetesOct 12, 2026
Midazolam, Ly5625573C-Reactive ProteinPhase IRecruitingA Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein)Oct 05, 2026―
[¹⁴C]-Ly4515100 Oral Solution, Ly4515100 Tablet, [¹⁴C]-Ly4515100 IvHealthyPhase IRecruitingA Study of LY4515100 in Healthy Male ParticipantsOct 05, 2026―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly And Company (CH:LLY) have in its pipeline
Eli Lilly & Co CH:LLY is currently developing the following drugs: Imlunestrant, Omeprazole, Ly3484356, Ly4247147, Ly3819469, Lepodisiran, Ly3841136, Eloralintide, Ly3873862, Cyp450 Drug Cocktail, Ly4167586, Tirzepatide, Eloralintide And Tirzepatide, Tirzepatide, Ly3841136, Eloralintide, Eloralintide And Tirzepatide, Midazolam, Ly5625573, [¹⁴C]-Ly4515100 Oral Solution, Ly4515100 Tablet, [¹⁴C]-Ly4515100 Iv, Florbetapir F18, Florbetaben F 18, Ly4560736, Donanemab, Ly3002813, Vepugratinib, Ly3866288, Selpercatinib, Tirzepatide, Oxaliplatin, Cetuximab, 5-Fluorouracil, Olomorasib, Leucovorin/Levofolinate Calcium, Ly3537982, Ly4329090, Combined Oral Contraceptive, Eloralintide, Ly3841136, Tirzepatide, Acetaminophen, Ly5625575, Abemaciclib Tablet, Abemaciclib Oral Granules, Orforglipron, Ly3502970, Florbetapir F18, Ly4405094, Florbetaben F 18, Clazakizumab, Brenipatide, Ly3537031, Eloralintide, Macupatide, Ly3532226, Midazolam, Ly4355756, Standard Of Care, Ly3537031, Brenipatide, Acetaminophen, Eloralintide, Ly3841136, Ly4268989, Eloralintide, Ly3841136, Ly4178256, Dulaglutide, Orforglipron, Ly3502970, High-Fat Meal, Tersolisib, Low-Fat Meal, Ly4064809, Ly4174794, Ly4065967. These drug candidates are in various stages of clinical development as the company works toward FDA approval.